Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas

To report the effect of cabergoline on ovarian hyperstimulation syndrome associated with gonadotropin-secreting pituitary adenomas. Case report. Outpatient practice. Two women with menstrual irregularity, enlarged ovaries, high E2, and normal gonadotropin levels. Cabergoline treatment and transsphen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fertility and sterility 2006-09, Vol.86 (3), p.719.e15-719.e18
Hauptverfasser: Knoepfelmacher, Mirta, Danilovic, Debora L.S., Rosa Nasser, Rubia H.R., Mendonça, Berenice B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 719.e18
container_issue 3
container_start_page 719.e15
container_title Fertility and sterility
container_volume 86
creator Knoepfelmacher, Mirta
Danilovic, Debora L.S.
Rosa Nasser, Rubia H.R.
Mendonça, Berenice B.
description To report the effect of cabergoline on ovarian hyperstimulation syndrome associated with gonadotropin-secreting pituitary adenomas. Case report. Outpatient practice. Two women with menstrual irregularity, enlarged ovaries, high E2, and normal gonadotropin levels. Cabergoline treatment and transsphenoidal surgery. Estradiol levels, transvaginal ultrasonography, and pituitary magnetic resonance imaging. Transsphenoidal surgery showed pituitary adenoma staining for LH in both patients. Cabergoline was effective in reducing E2 levels and decreasing ovarian size but ineffective in shrinking the pituitary adenomas. This is the first description of the effectiveness of cabergoline as the primary treatment of spontaneous ovarian hyperstimulation syndrome in patients with gonadotropin-producing pituitary adenomas.
doi_str_mv 10.1016/j.fertnstert.2006.01.055
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68821299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028206010181</els_id><sourcerecordid>68821299</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-f9572fc57d1b0fc63dfca627ae588ea19edacc349c4bfb733638dc32f41188163</originalsourceid><addsrcrecordid>eNqFkc1u3CAQgFHVKNkmeYWKU292AS8YH9soaStF6qU9IwzDhpUNLuCN9hn60mW1K-XYy3CYb36YDyFMSUsJFZ_3rYNUQi41towQ0RLaEs7foQ3lXDRc8O492hBCeUOYZDfoQ857UkHas2t0Q8XAGafdBv19dA5M8QcIkDOODpcEuviww_Ggk9cBvxwXSLn4eZ1qIgacj8GmOAN-9eUFGz1C2sXJB8A-4PIa8VI5CCWfgV0M2saS4uJDs6RoV3Nqv_iy-qLTEWsLIc4636Erp6cM95f3Fv1-evz18L15_vntx8OX58ZsGSuNG3jPnOG9pSNxRnTWGS1Yr4FLCZoOYLUx3XYw29GNfdeJTlrTMbelVEoqulv06dy3LvNnhVzU7LOBadIB4pqVkJJRNgwVlGfQpJhzAqeW5Oe6sqJEnUSovXoToU4iFKGqiqilHy8z1nEG-1Z4uXwFvp4BqD89eEgqm3o0A9anKkTZ6P8_5R9IDKVn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68821299</pqid></control><display><type>article</type><title>Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Knoepfelmacher, Mirta ; Danilovic, Debora L.S. ; Rosa Nasser, Rubia H.R. ; Mendonça, Berenice B.</creator><creatorcontrib>Knoepfelmacher, Mirta ; Danilovic, Debora L.S. ; Rosa Nasser, Rubia H.R. ; Mendonça, Berenice B.</creatorcontrib><description>To report the effect of cabergoline on ovarian hyperstimulation syndrome associated with gonadotropin-secreting pituitary adenomas. Case report. Outpatient practice. Two women with menstrual irregularity, enlarged ovaries, high E2, and normal gonadotropin levels. Cabergoline treatment and transsphenoidal surgery. Estradiol levels, transvaginal ultrasonography, and pituitary magnetic resonance imaging. Transsphenoidal surgery showed pituitary adenoma staining for LH in both patients. Cabergoline was effective in reducing E2 levels and decreasing ovarian size but ineffective in shrinking the pituitary adenomas. This is the first description of the effectiveness of cabergoline as the primary treatment of spontaneous ovarian hyperstimulation syndrome in patients with gonadotropin-producing pituitary adenomas.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/j.fertnstert.2006.01.055</identifier><identifier>PMID: 16952513</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenoma ; Adult ; Antineoplastic Agents - therapeutic use ; cabergoline ; Ergolines - therapeutic use ; Female ; Gonadotropin-secreting pituitary adenoma ; Gonadotropins - metabolism ; Humans ; Ovarian Hyperstimulation Syndrome - complications ; Ovarian Hyperstimulation Syndrome - drug therapy ; Ovarian Hyperstimulation Syndrome - metabolism ; Pituitary Neoplasms - complications ; Pituitary Neoplasms - drug therapy ; Pituitary Neoplasms - metabolism ; spontaneous ovarian hyperstimulation syndrome</subject><ispartof>Fertility and sterility, 2006-09, Vol.86 (3), p.719.e15-719.e18</ispartof><rights>2006 American Society for Reproductive Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-f9572fc57d1b0fc63dfca627ae588ea19edacc349c4bfb733638dc32f41188163</citedby><cites>FETCH-LOGICAL-c422t-f9572fc57d1b0fc63dfca627ae588ea19edacc349c4bfb733638dc32f41188163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0015028206010181$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16952513$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Knoepfelmacher, Mirta</creatorcontrib><creatorcontrib>Danilovic, Debora L.S.</creatorcontrib><creatorcontrib>Rosa Nasser, Rubia H.R.</creatorcontrib><creatorcontrib>Mendonça, Berenice B.</creatorcontrib><title>Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>To report the effect of cabergoline on ovarian hyperstimulation syndrome associated with gonadotropin-secreting pituitary adenomas. Case report. Outpatient practice. Two women with menstrual irregularity, enlarged ovaries, high E2, and normal gonadotropin levels. Cabergoline treatment and transsphenoidal surgery. Estradiol levels, transvaginal ultrasonography, and pituitary magnetic resonance imaging. Transsphenoidal surgery showed pituitary adenoma staining for LH in both patients. Cabergoline was effective in reducing E2 levels and decreasing ovarian size but ineffective in shrinking the pituitary adenomas. This is the first description of the effectiveness of cabergoline as the primary treatment of spontaneous ovarian hyperstimulation syndrome in patients with gonadotropin-producing pituitary adenomas.</description><subject>Adenoma</subject><subject>Adult</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>cabergoline</subject><subject>Ergolines - therapeutic use</subject><subject>Female</subject><subject>Gonadotropin-secreting pituitary adenoma</subject><subject>Gonadotropins - metabolism</subject><subject>Humans</subject><subject>Ovarian Hyperstimulation Syndrome - complications</subject><subject>Ovarian Hyperstimulation Syndrome - drug therapy</subject><subject>Ovarian Hyperstimulation Syndrome - metabolism</subject><subject>Pituitary Neoplasms - complications</subject><subject>Pituitary Neoplasms - drug therapy</subject><subject>Pituitary Neoplasms - metabolism</subject><subject>spontaneous ovarian hyperstimulation syndrome</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u3CAQgFHVKNkmeYWKU292AS8YH9soaStF6qU9IwzDhpUNLuCN9hn60mW1K-XYy3CYb36YDyFMSUsJFZ_3rYNUQi41towQ0RLaEs7foQ3lXDRc8O492hBCeUOYZDfoQ857UkHas2t0Q8XAGafdBv19dA5M8QcIkDOODpcEuviww_Ggk9cBvxwXSLn4eZ1qIgacj8GmOAN-9eUFGz1C2sXJB8A-4PIa8VI5CCWfgV0M2saS4uJDs6RoV3Nqv_iy-qLTEWsLIc4636Erp6cM95f3Fv1-evz18L15_vntx8OX58ZsGSuNG3jPnOG9pSNxRnTWGS1Yr4FLCZoOYLUx3XYw29GNfdeJTlrTMbelVEoqulv06dy3LvNnhVzU7LOBadIB4pqVkJJRNgwVlGfQpJhzAqeW5Oe6sqJEnUSovXoToU4iFKGqiqilHy8z1nEG-1Z4uXwFvp4BqD89eEgqm3o0A9anKkTZ6P8_5R9IDKVn</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Knoepfelmacher, Mirta</creator><creator>Danilovic, Debora L.S.</creator><creator>Rosa Nasser, Rubia H.R.</creator><creator>Mendonça, Berenice B.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060901</creationdate><title>Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas</title><author>Knoepfelmacher, Mirta ; Danilovic, Debora L.S. ; Rosa Nasser, Rubia H.R. ; Mendonça, Berenice B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-f9572fc57d1b0fc63dfca627ae588ea19edacc349c4bfb733638dc32f41188163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adenoma</topic><topic>Adult</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>cabergoline</topic><topic>Ergolines - therapeutic use</topic><topic>Female</topic><topic>Gonadotropin-secreting pituitary adenoma</topic><topic>Gonadotropins - metabolism</topic><topic>Humans</topic><topic>Ovarian Hyperstimulation Syndrome - complications</topic><topic>Ovarian Hyperstimulation Syndrome - drug therapy</topic><topic>Ovarian Hyperstimulation Syndrome - metabolism</topic><topic>Pituitary Neoplasms - complications</topic><topic>Pituitary Neoplasms - drug therapy</topic><topic>Pituitary Neoplasms - metabolism</topic><topic>spontaneous ovarian hyperstimulation syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Knoepfelmacher, Mirta</creatorcontrib><creatorcontrib>Danilovic, Debora L.S.</creatorcontrib><creatorcontrib>Rosa Nasser, Rubia H.R.</creatorcontrib><creatorcontrib>Mendonça, Berenice B.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Knoepfelmacher, Mirta</au><au>Danilovic, Debora L.S.</au><au>Rosa Nasser, Rubia H.R.</au><au>Mendonça, Berenice B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>86</volume><issue>3</issue><spage>719.e15</spage><epage>719.e18</epage><pages>719.e15-719.e18</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><abstract>To report the effect of cabergoline on ovarian hyperstimulation syndrome associated with gonadotropin-secreting pituitary adenomas. Case report. Outpatient practice. Two women with menstrual irregularity, enlarged ovaries, high E2, and normal gonadotropin levels. Cabergoline treatment and transsphenoidal surgery. Estradiol levels, transvaginal ultrasonography, and pituitary magnetic resonance imaging. Transsphenoidal surgery showed pituitary adenoma staining for LH in both patients. Cabergoline was effective in reducing E2 levels and decreasing ovarian size but ineffective in shrinking the pituitary adenomas. This is the first description of the effectiveness of cabergoline as the primary treatment of spontaneous ovarian hyperstimulation syndrome in patients with gonadotropin-producing pituitary adenomas.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>16952513</pmid><doi>10.1016/j.fertnstert.2006.01.055</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-0282
ispartof Fertility and sterility, 2006-09, Vol.86 (3), p.719.e15-719.e18
issn 0015-0282
1556-5653
language eng
recordid cdi_proquest_miscellaneous_68821299
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adenoma
Adult
Antineoplastic Agents - therapeutic use
cabergoline
Ergolines - therapeutic use
Female
Gonadotropin-secreting pituitary adenoma
Gonadotropins - metabolism
Humans
Ovarian Hyperstimulation Syndrome - complications
Ovarian Hyperstimulation Syndrome - drug therapy
Ovarian Hyperstimulation Syndrome - metabolism
Pituitary Neoplasms - complications
Pituitary Neoplasms - drug therapy
Pituitary Neoplasms - metabolism
spontaneous ovarian hyperstimulation syndrome
title Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A48%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20treating%20ovarian%20hyperstimulation%20syndrome%20with%20cabergoline%20in%20two%20patients%20with%20gonadotropin-producing%20pituitary%20adenomas&rft.jtitle=Fertility%20and%20sterility&rft.au=Knoepfelmacher,%20Mirta&rft.date=2006-09-01&rft.volume=86&rft.issue=3&rft.spage=719.e15&rft.epage=719.e18&rft.pages=719.e15-719.e18&rft.issn=0015-0282&rft.eissn=1556-5653&rft_id=info:doi/10.1016/j.fertnstert.2006.01.055&rft_dat=%3Cproquest_cross%3E68821299%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68821299&rft_id=info:pmid/16952513&rft_els_id=S0015028206010181&rfr_iscdi=true